Orviva

Learn · Variants · SLC30A8

rs13266634 SLC30A8

SLC30A8 Arg325Trp. Increased T2D risk; affects zinc transport in pancreatic beta cells.

Curated · human-reviewed Health risk · Risk / effect allele: C · dbSNP

What is rs13266634?

rs13266634 is a single-nucleotide polymorphism (SNP) in the SLC30A8 gene (Solute carrier family 30 member 8 (zinc transporter 8)). Each person carries two copies, one from each parent, so a result is reported as a pair of letters such as CC. The table below describes what studies associate with each genotype; the association is statistical, across populations, and is not a diagnosis.

What does each rs13266634 genotype mean?

GenotypeAssociationWhat the evidence saysConfidence
CCslightly elevatedSLC30A8 Arg325Trp. Increased T2D risk; affects zinc transport in pancreatic beta cells.80%
CT / TCtypicalIntermediate T2D risk at SLC30A8.77%
TTtypical / lowerProtective allele at SLC30A8. Reduced T2D risk.80%

How common is the C allele of rs13266634?

Minor-allele frequency by population (gnomAD / 1000 Genomes):

European30.0%
East Asian46.0%
African7.0%
South Asian26.0%
Admixed American22.0%
Global27.0%

Which drugs have annotations for rs13266634?

PharmGKB clinical annotations (level 1A is the strongest evidence, 4 the weakest):

DrugAnnotation typeEvidence level
repaglinideEfficacy3
insulin recombinantEfficacy3
zinc acetateEfficacy3

Is rs13266634 on 23andMe and AncestryDNA chips?

Yes — it is genotyped directly on 23andMe V3, 23andMe V4, 23andMe V5, AncestryDNA V1, AncestryDNA V2. Orviva reads it from a raw-data export without imputation.

Sources

Genetic associations describe risk across populations, not a diagnosis for any one person. Most variants shift risk modestly and act alongside lifestyle, environment and other genes. Consumer DNA chips do not read every position and can be wrong at any single one. For general education only; talk to a clinician or genetic counsellor before acting on anything here, and never change a prescribed medicine without your prescriber.